Association of acute-course electroconvulsive therapy pathway markers with same-hospital psychiatric readmission in patients with major depressive disorder: A retrospective cohort study.
Sep 2026· Journal of Affective Disorders· Vol 416, pp.
122548
· 0 citations· 31 references
Medicine
TL;DR
Acute-course ECT pathway markers were not detectably associated with same-hospital psychiatric readmission in baseline-adjusted marker-specific models and there was no evidence of effect modification by baseline suicidality.
Abstract
Background
Electroconvulsive therapy (ECT) is an effective acute treatment for severe major depressive disorder (MDD), but whether two routinely captured acute-course ECT pathway markers-time from admission to first ECT and total acute-course session count-are associated with longer-term readmission is unclear. We examined their associations with same-hospital psychiatric readmission, overall and across baseline suicidality.
Methods
This retrospective cohort study included 4004 inpatients with MDD who received modified ECT during the index hospitalization at a tertiary psychiatric hospital in China (2013-2020); each patient contributed only the earliest qualifying hospitalization. Baseline suicidality was classified as none documented, ideation, or behavior. Separate marker-specific Cox models estimated baseline-adjusted associations with same-hospital psychiatric readmission within 180 and 365 days.
Results
Readmission occurred in 449 patients (11.2%) by 180 days and 593 (14.8%) by 365 days. Neither time from admission to first ECT (hazard ratio [HR], 1.002 per day; 95% confidence interval [CI], 0.989-1.016) nor session count (HR, 1.003 per session; 95% CI, 0.970-1.037) was associated with 180-day readmission; findings were similar at 365 days. There was no evidence of effect modification by baseline suicidality. Total psychiatric hospitalizations including the index hospitalization showed a graded association with readmission. Sensitivity analyses were consistent.
Limitations
This single-center electronic health record study did not capture other-institution readmission, mortality, or continuation ECT, and could not distinguish planned from unplanned readmissions.
Conclusions
Acute-course ECT pathway markers were not detectably associated with same-hospital psychiatric readmission in baseline-adjusted marker-specific models. Findings should not be generalized to symptomatic relapse, other-institution readmission, or all-cause outcomes.
BACKGROUND
Relapse after a first manic episode is common in bipolar I disorder and frequently leads to rehospitalization. Lithium and valproate, often prescribed with atypical antipsychotics, remain central to maintenance therapy; however, no randomized trials have directly compared these regimens in early-course illne...
Pei-Ying Li, Meng-Ting Wang, J. Jeng et al.· Bipolar Disorders· 0 citations
These findings suggest that standard clinical variables may hold predictive value for early readmission in MDD, however, external validation, assessment of model calibration, and clinical utility are needed prior to clinical implementation.
F. Bartoli, M. Luciano, C. Crocamo et al.· Journal of Affective Disorde...· 0 citations
BACKGROUND
Substance use disorders frequently co-occur with severe mental illness (SMI), and individuals with co-occurring diagnoses often experience greater clinical complexity and poorer treatment outcomes. However, little is known about treatment engagement and outcomes among patients with SMI receiving inpatient ad...
Sean T. Lynch, Kathryn Stevens, William Fletes et al.· Journal of substance use and...· 0 citations
BACKGROUND
Data on clinical outcomes in psychotic depression remain limited. We examined hospitalization, suicide, and treatment patterns in Swedish patients with psychotic depression.
METHODS
This nationwide register-based study included patients with an index diagnosis of psychotic unipolar depression during 2012-2...
Ahmed Al-Wandi, A. Nordenskjöld· Journal of Affective Disorde...· 0 citations
Nighttime sensory-behavioral activation was associated with admission suicidality and, at the marked level, severe social role impairment in young inpatients with major depressive disorder.
Sustained psychiatric medication after a suicide attempt reduces one-year reattempt risk in patients with depression, in particular in those aged under 65 years, in particular in those aged under 65 years.
J. Yang, Min Ji Kim, S. Rhee et al.· Journal of Affective Disorde...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.